NLRP3 inflammasome in cardiovascular diseases: Pathophysiological and pharmacological implications
Author:
Affiliation:
1. Department of Pharmacy University of Pisa Pisa Italy
2. Department of Clinical and Experimental Medicine, Unit of Pharmacology and Pharmacovigilance University of Pisa Pisa Italy
Publisher
Wiley
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.21781
Reference181 articles.
1. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases
2. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
3. Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
4. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury
5. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives;Ozaki E;J Inflamm Res,2015
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel NLRP3 inhibitor INF195: Low doses provide effective protection against myocardial ischemia/reperfusion injury;Vascular Pharmacology;2024-09
2. The beneficial health effects of puerarin in the treatment of cardiovascular diseases: from mechanisms to therapeutics;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-06
3. La relación hiperuricemia-HSP70-NLRP3 inflamosoma en la hipertensión arterial;Archivos de Cardiología de México;2024-01-10
4. Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy;BMC Medicine;2024-01-08
5. Estrogen plays an important role by influencing the NLRP3 inflammasome;Biomedicine & Pharmacotherapy;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3